Elevation Oncology Inc (ELEV)
4.02
-0.05
(-1.23%)
USD |
NASDAQ |
May 31, 16:00
4.04
+0.02
(+0.50%)
After-Hours: 20:00
Elevation Oncology Total Assets (Quarterly): 108.96M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 108.96M |
| December 31, 2023 | 89.09M |
| September 30, 2023 | 99.98M |
| June 30, 2023 | 110.37M |
| March 31, 2023 | 76.90M |
| December 31, 2022 | 94.16M |
| September 30, 2022 | 111.49M |
| Date | Value |
|---|---|
| June 30, 2022 | 123.78M |
| March 31, 2022 | 134.31M |
| December 31, 2021 | 149.49M |
| September 30, 2021 | 158.52M |
| June 30, 2021 | 159.06M |
| March 31, 2021 | 71.76M |
| December 31, 2020 | 80.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
71.76M
Minimum
Mar 2021
159.06M
Maximum
Jun 2021
112.06M
Average
109.67M
Median
Total Assets (Quarterly) Benchmarks
| Merrimack Pharmaceuticals Inc (DELISTED) | 244.32M |
| TG Therapeutics Inc | 373.32M |
| Mersana Therapeutics Inc | 198.37M |
| Equillium Inc | 43.60M |
| Monopar Therapeutics Inc | 8.912M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.14M |
| Shareholders Equity (Quarterly) | 75.82M |